A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis	Recruiting	Phase 1 / Phase 2	2026-10-02		NCT04176198

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sumitomo Pharma America, Inc.	16

91 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aichi Medical University Hospital	Aichi	Japan	2
Aomori Prefectural Central Hospital	Aomori	Japan	2
ASST - Spedali Civili di Brescia	Brescia	Italy	1
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo	Alessandria	Italy	2
Azienda Ospedaliera Universitaria Citta' Della Salute E della Scienza di Torino	Torino	Italy	1
Baptist Health - Miami Cancer Institute	Miami	United States	2
Blood Cancer Center	Denver	United States	1
Centre Hospitalier Lyon Sud	Lyon	France	4
Centre Hospitalier Universitaire D'Amiens	Amiens	France	2
CHU Angers	Angers	France	1
CHU de Liege	Liège	Belgium	21
City of Hope	Duarte	United States	238
Duke Cancer Institute	Durham	United States	47
Eastern Health Box Hill Hospital	Box Hill	Australia	1
Emory University	Atlanta	United States	262
Epworth Healthcare	Richmond	Australia	1
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico	Milan	Italy	44
Hoag Family Cancer Institute	Newport Beach	United States	6
Hokkaido University Hospital	Hokkaido	Japan	8
Hospital Saint Louis	Paris	France	9
Hospital Universitario de Salamanca	Salamanca	Spain	29
Hospital Universitario y Politecnico La Fe	Barcelona	Spain	1
Hospitalier Universitaire (CHU) de Nice - Hopital de l'Archet	Nice	France	1
Huntsman Cancer Institute	Salt Lake City	United States	107
Icahn School of Medicine at Mount Sinai	New York	United States	342

Clinical trials